Published in TB and Outbreaks Week, November 6th, 2001
The company also announced that recent improvements to QuickVue allow it to be stored at room temperature and with no special handling or storage requirements for up to two years from the date of manufacture.
"We estimate the global rapid influenza testing market at $23 million last year, and with the recent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.